Federal Cannabis Rescheduling Is on Hold. What It Changes for Your Insurance, and What It Doesn’t

Status as of October 7, 2026: On September 29, 2026, the Drug Enforcement Administration’s Chief Administrative Law Judge, Derek C. Julius, stayed the proceeding on whether to move all marijuana to Schedule III (DEA Docket No. 1362). The government’s response to the motion behind the stay is due October 13, 2026. No restart date has been set.

Federal cannabis policy has a talent for making news without making changes. If you run a state-licensed cannabis business, someone has probably asked you a version of this already: a landlord, a lender, a new partner. “Once rescheduling goes through, the insurance gets easier, right?” Fair question. Here is where things actually stand, written for state-licensed operators wherever you are licensed, with California license types as the working example. This is brokerage guidance only. It is not legal or tax advice.

What happened on September 29

The merits hearing on the broader rescheduling proposal ran from June 29 to July 15, 2026. On September 28, three interested parties asked the judge to add a U.S. Government Accountability Office report on federal drug-scheduling procedures, published September 23, to the record, to allow extra briefing on it, and to pause the case in the meantime. The next day, the judge stayed the case while he decides that motion.

The order does not admit the report. It does not decide anything about where marijuana belongs. It sets no date for the judge’s recommended decision, and after that recommendation the process still has steps left, including the parties’ exceptions and a final decision by the agency.

In plain terms: the hearing is over, and the paperwork is not. Anyone who has waited three weeks for a certificate holder to approve one line on an additional insured endorsement knows exactly how this feels.

What already changed in April

A separate final order published in the Federal Register on April 28, 2026 placed two things in Schedule III: FDA-approved drug products containing marijuana, and marijuana subject to a state medical marijuana license. It also created an expedited DEA registration path for state medical licensees. The same order states that any other marijuana remains in Schedule I.

The September stay does not touch that April order. So the federal picture today is split. Marijuana under a state medical license sits in Schedule III. Adult-use marijuana is still in Schedule I. In California, that maps roughly to the medicinal (M) and adult-use (A) license designations, and plenty of operators hold both. Whether a specific license and activity fits the April order is a question for your counsel. What matters for insurance is that underwriters will ask, and your answer should match your licenses exactly.

What the stay does not change on your policy

• Your current policy wording. A policy is a contract. Coverage grants, exclusions, limits, and conditions do not change because a federal hearing paused. They change by endorsement or at renewal.
• Where the risk gets placed. Commercial cannabis coverage is still placed mostly through specialty and surplus lines markets. In California, the surplus lines Export List update made the placement paperwork simpler. It did not turn cannabis into an admitted-market class. Our surplus lines Export List explainer covers that in detail.
• The federal safe harbor for insurers. The CLAIM Act would bar federal regulators from penalizing insurers, brokers, and agents for serving state-licensed cannabis businesses. It is pending in both chambers. S. 5049 was introduced July 21, 2026, and a House companion was reintroduced September 16, 2026. Both are in committee. Even if it passes, it would not require any insurer to write cannabis.
• State requirements. Insurance and bond requirements tied to your license come from your state. In California, the DCC licensee bond and the general liability requirement for distributors still apply exactly as before.

What to check now

• Tell your broker which license types you hold, by premises. Medical, adult-use, or both. With a split federal schedule, the submission should say which is which.
• Read the cannabis and controlled-substance language. Look at how your policy defines cannabis and whether any exclusion turns on federal law. Many general-market forms exclude cannabis outright, while cannabis programs are written around that exposure. Know which one you have before you need it.
• Check product liability and recall. A rescheduling headline does not change product exposure. If you manufacture, distribute, or sell, confirm your product liability limits and whether recall expense is covered at all. See cannabis product liability and cannabis product recall insurance.
• Do not rewrite contracts on a headline. If a landlord, lender, or partner wants to loosen or tighten insurance terms “because of rescheduling,” check the actual status first. Today that status is: April order in effect, broader proposal on hold.
• Hemp-derived product sellers: mark November 12, 2026. The April order notes that the federal hemp definition changes that day to a total-THC test, including THCA, of not more than 0.3 percent on a dry weight basis. If any product line depends on the current definition, talk with counsel and your broker before then.

What to watch next

October 13, 2026 is the response deadline. After that, the judge decides whether to admit the GAO report, whether to allow more briefing, and when to lift the stay. We will update this post when the stay lifts or a ruling issues. Until then, plan around the rules in force today, not the ones in the headlines.

Related reading: cannabis business insurance, California cannabis insurance, and what cannabis businesses usually get asked for insurance.

Sources: DEA Office of Administrative Law Judges, Order Staying Case and Ordering Response to Motion, DEA Docket No. 1362, Hearing Docket No. 26-96 (Sept. 29, 2026); Federal Register Doc. 2026-08176 (Apr. 28, 2026); Congress.gov, S. 5049, CLAIM Act; Insurance Business, House CLAIM Act reintroduction (Sept. 17, 2026).

Talk to a licensed producer about your cannabis program
State-licensed cannabis operators · Medical, adult-use, or both
Call (916) 967-7715 or request a quote and a Lions & Coventry producer will follow up.
We review appetite honestly, with no guaranteed-placement language. CDI License #0G22084.
Lions & Coventry Insurance Services — brokerage guidance only, not legal or tax advice.